HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$7.91
Day range
$7.95 - $8.72
Year range
$3.25 - $14.44
Market cap
701.42M USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.18M | 22.20% |
Net income | -12.11M | -40.47% |
Net profit margin | — | — |
Earnings per share | -0.14 | -27.27% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 120.78M | -15.99% |
Total assets | 124.04M | -16.23% |
Total liabilities | 13.13M | 5.07% |
Total equity | 110.92M | — |
Shares outstanding | 85.06M | — |
Price to book | 6.04 | — |
Return on assets | -25.38% | — |
Return on capital | -28.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.11M | -40.47% |
Cash from operations | -12.12M | -65.62% |
Cash from investing | — | — |
Cash from financing | 708.00K | 1,100.00% |
Net change in cash | -11.41M | -57.21% |
Free cash flow | -8.25M | -51.67% |
About
Founded
2001
Headquarters
Website
Employees
42
